Literature DB >> 25926404

Targeting core groups for gonorrhoea control: feasibility and impact.

Katia Giguère1, Michel Alary2.   

Abstract

OBJECTIVE: We aimed to outline why core groups should be targeted in Neisseria gonorrhoeae control and suggest several important and timely interventions to target core groups while highly resistant strains are spreading.
METHODS: Core group definition, feasibility and impact of gonorrhoea core group interventions as well as gonorrhoea resistance development have been reviewed in the paper.
RESULTS: Core group interventions have proven effective in gonorrhoea control in the past but are compromised by the spread of highly resistant strains.
CONCLUSIONS: Worldwide functional Gonorrhoea Antimicrobial Surveillance Program, better screening and better treatment programmes are needed. Prevention through condom promotion aimed at core groups remains essential. More specific treatment guidance for low-income and middle-income countries without resistance data is required in the meantime to achieve a better use of antibiotics. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  ANTIMICROBIAL RESISTANCE; CONTROL PROGRAMS; INTERVENTION STUDIES; NEISSERIA GONORRHOEA

Mesh:

Substances:

Year:  2015        PMID: 25926404     DOI: 10.1136/sextrans-2014-051732

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  2 in total

1.  Temporal Variation in One-Time Partnership Rates Among Young Men Who Have Sex With Men and Transgender Women.

Authors:  Patrick Janulis; Steven M Goodreau; Michelle Birkett; Gregory Phillips; Martina Morris; Brian Mustanski; Samuel M Jenness
Journal:  J Acquir Immune Defic Syndr       Date:  2021-07-01       Impact factor: 3.771

2.  Quantifying HIV transmission flow between high-prevalence hotspots and surrounding communities: a population-based study in Rakai, Uganda.

Authors:  Oliver Ratmann; Joseph Kagaayi; Matthew Hall; Tanya Golubchick; Godfrey Kigozi; Xiaoyue Xi; Chris Wymant; Gertrude Nakigozi; Lucie Abeler-Dörner; David Bonsall; Astrid Gall; Anne Hoppe; Paul Kellam; Jeremiah Bazaale; Sarah Kalibbala; Oliver Laeyendecker; Justin Lessler; Fred Nalugoda; Larry W Chang; Tulio de Oliveira; Deenan Pillay; Thomas C Quinn; Steven J Reynolds; Simon E F Spencer; Robert Ssekubugu; David Serwadda; Maria J Wawer; Ronald H Gray; Christophe Fraser; M Kate Grabowski
Journal:  Lancet HIV       Date:  2020-01-14       Impact factor: 12.767

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.